Cleviprex
NDC 10122-611, clevipidine, emulsion, from Chiesi USA, Inc..
- Product NDC
- 10122-611
- Status
- Listed
- Labeler
- Chiesi USA, Inc.
- Dosage form
- EMULSION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022156
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10122-611 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CLEVIDIPINE.5 mg/mL
Pharmacologic classes
Calcium Channel Antagonists [MoA]; Dihydropyridine Calcium Channel Blocker [EPC]; Dihydropyridines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10122-611-10 | 10122061110 | 10 CARTON in 1 CARTON (10122-611-10) / 1 VIAL, SINGLE-USE in 1 CARTON (10122-611-01) / 100 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/f9290625-b723-4eda-bab8-a97bef6041f6Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=10122-611
Use it
Look up 10122-611 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10122-611 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10122-611. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.